ONDANSETRON

NDC 51662-1366 · HF Acquisition Co LLC, DBA HealthFirst

Generic nameONDANSETRON

Dosage formINJECTION

RouteINTRAMUSCULAR, INTRAVENOUS

Active ingredient(s)ONDANSETRON HYDROCHLORIDE

Strength2 mg/mL

Pharmacologic classSerotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]

Marketing categoryANDA

Packages

51662-1366-1 — 2 mL in 1 VIAL (51662-1366-1)

FDA lists these products with the same active ingredient.

50268-621 — Ondansetron Hydrochloride, 50268-622 — Ondansetron Hydrochloride, 50268-647 — Ondansetron, 51407-003 — Ondansetron, 51407-004 — Ondansetron, 51655-016 — Ondansetron Hydrochloride, 51655-415 — Ondansetron Hydrochloride, 51655-813 — Ondansetron Hydrochloride, 51655-933 — Ondansetron Hydrochloride, 51662-1245 — ONDANSETRON, 51662-1377 — ONDANSETRON, 51662-1469 — ONDANSETRON, 51662-1539 — ONDANSETRON, 51662-1678 — ONDANSETRON, 54348-819 — ONDANSETRON, 54348-821 — Ondansetron Hydrochloride, 55111-153 — ONDANSETRON HYDROCHLORIDE, 55111-154 — ONDANSETRON HYDROCHLORIDE, 55111-155 — ondansetron hydrochloride, 55111-156 — ONDANSETRON HYDROCHLORIDE, +154 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.